share_log

News Highlights: Top company news on 7/13

Dow Jones Newswires ·  Jul 13, 2021 05:04  · Trending
  • China Clears $Tencent(00700.HK)$-$Sogou(SOGO.US)$ Deal

    China's top market watchdog approved Tencent's plan to privatize search-engine affiliate Sogou in a deal that comes as the country's technology giants face heightened antitrust scrutiny.

  • $Nokia Oyj(NOK.US)$ to Raise Full-Year Outlook

    Nokia said it expects to upgrade its guidance for 2021 after experiencing continued business strength during the second quarter.

  • Hg to Make $1 Billion Investment in Insightsoftware

    A new investment for the maker of financial-reporting software values the private-equity-backed company at around $4 billion

  • Chinese Developer Languang Development Slips on Bond Default

    Shares of $Sichuan Languang Development(600466.SH)$ are hovering near a decade low after the company defaulted on a bond, the latest sign of trouble in China's heavily indebted property-development sector.

  • Volvo Trucks Aims to Reopen Factory After Third Contract Rejection

    Volvo Trucks North America says it plans to resume production at its truck manufacturing plant in Dublin, Va., despite a third vote by unionized workers rejecting a tentative contract settlement aimed at ending a monthlong walkout at the factory.

  • $Boeing Co(BA.US)$ Faces New Dreamliner Production Problem

    A new production problem has surfaced with Boeing's 787 Dreamliner, likely further delaying deliveries of the popular wide-body jets, people familiar with the matter said.

  • $Microsoft Corp(MSFT.US)$ to Buy Cybersecurity Firm RiskIQ

    The deal would add to Microsoft's portfolio of security services amid a rise in high-profile online attacks.

  • IFIT to Buy Fitness Platform Sweat for $300 Million Ahead of IPO

    The NordicTrack owner is expected to fetch a valuation over $7 billion in an IPO this fall.

  • Medicare to Review Coverage for New Alzheimer's Drug Aduhelm

    The review of $Biogen Inc(BIIB.US)$'s drug will include an analysis of published clinical studies and medical society guidelines, as well as two public hearings

Source: Dow Jones Newswires

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment